Luke Bevan
Impact in
-
- Neonatal Respiratory Health Research
- Cystic Fibrosis Research Advances
- Chronic Obstructive Pulmonary Disease (COPD) Research
Papers in
-
- Cystic Fibrosis Research Advances 2
- Neonatal Respiratory Health Research 1
-
- Bacterial Infections and Vaccines 1
- Microbial infections and disease research 1
- Co-authors
- Pasquale Marrazzo (1 shared paper)Silvia Maccari (1 shared paper)Alfredo Pezzicoli (1 shared paper)John L. Telford (1 shared paper)Annarita Taddei (1 shared paper)Marco Soriani (1 shared paper)Katherine J. Choy (1 shared paper)Carina Gross (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Pharmacology & Therapeutics (1 paper)Molecular Cancer Therapeutics (1 paper)Cell Reports (1 paper)PLoS ONE (1 paper)
- Partner nations
- United KingdomItaly
In The Last Decade
Luke Bevan
6 papers receiving 337 citations
Peers
Comparison fields: 5 of 55
- Pulmonary and Respiratory Medicine 130
- Drug Discovery 1
- Physiology 41
- Oncology 35
- Molecular Biology 92
Countries citing papers authored by Luke Bevan
This map shows the geographic impact of Luke Bevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Bevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Bevan more than expected).
Fields of papers citing papers by Luke Bevan
This network shows the impact of papers produced by Luke Bevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Bevan. The network helps show where Luke Bevan may publish in the future.
Co-authors
The 8 scholars most cited alongside Luke Bevan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 208 | |
| 2 | 2021 | 48 | |
| 3 | 2016 | 38 | |
| 4 | 2021 | 25 | |
| 5 | 2021 | 18 | |
| 6 | 2013 | 17 |
About Luke Bevan
Luke Bevan is a scholar working on Pulmonary and Respiratory Medicine, Microbiology, Hepatology, Molecular Biology and Oncology, having authored 6 papers that have together received 354 indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (2 papers), Cystic Fibrosis Research Advances (2 papers), Neonatal Respiratory Health Research (1 paper), Bacterial Infections and Vaccines (1 paper), Liver physiology and pathology (1 paper), Cancer-related Molecular Pathways (1 paper), Developmental Biology and Gene Regulation (1 paper) and Microbial infections and disease research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (130 citations), Drug Discovery (1 citation), Physiology (41 citations), Oncology (35 citations) and Molecular Biology (92 citations). Luke Bevan has collaborated with scholars based in United Kingdom and Italy. Frequent co-authors include Pasquale Marrazzo, Silvia Maccari, Alfredo Pezzicoli, John L. Telford, Annarita Taddei, Marco Soriani, Katherine J. Choy and Carina Gross. Their work appears in journals such as Journal of Medicinal Chemistry, Pharmacology & Therapeutics, Molecular Cancer Therapeutics, Cell Reports and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.